Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (471-480 of 584) with videos related to

Pageof 59
Sort By:
Malaria Journal|May 28, 2013
Epidemiology of Plasmodium infections in Flores Island, Indonesia using real-time PCRMaria M M Kaisar, Taniawati Supali, Aprilianto E Wiria, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2015
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trialsF Duffaud, S Sleijfer, S Litière, et al.
The American Journal of Tropical Medicine and Hygiene|February 7, 2018
Island-Wide Surveillance of Gastrointestinal Protozoan Infection on Fiji by Expanding Lymphatic Filariasis Transmission Assessment Surveys as an Access PlatformSung Hye Kim, Milika Rinamalo, Meleresita Rainima-Qaniuci, et al.
The Journal of Urology|August 1, 1989
Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinomaJ H Schornagel, J Verweij, W W ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupM Debiec-Rychter, H Dumez, I Judson, et al.
British Journal of Cancer|December 25, 2013
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I studyP Hamberg, M J Boers-Sonderen, W T A van der Graaf, et al.
Anti-Cancer Drugs|August 13, 2002
The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumorsH Dumez, M Louwerens, A Pawinsky, et al.
Medical Mycology Case Reports|February 9, 2019
Two cases of <i>Emergomyces pasteurianus</i> infection in immunocompromised patients in the NetherlandsKarin B Gast, Alieke van der Hoeven, Mark G J de Boer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Journal of Extracellular Vesicles|November 7, 2024
Hypoxia and TNF-alpha modulate extracellular vesicle release from human induced pluripotent stem cell-derived cardiomyocytesMargarida Viola, Maarten P Bebelman, Renee G C Maas, et al.
Pageof 59

Showing results (471-480 of 584) with videos related to

Sort By:
Pageof 59
Malaria Journal|May 28, 2013
Epidemiology of Plasmodium infections in Flores Island, Indonesia using real-time PCRMaria M M Kaisar, Taniawati Supali, Aprilianto E Wiria, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2015
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trialsF Duffaud, S Sleijfer, S Litière, et al.
The American Journal of Tropical Medicine and Hygiene|February 7, 2018
Island-Wide Surveillance of Gastrointestinal Protozoan Infection on Fiji by Expanding Lymphatic Filariasis Transmission Assessment Surveys as an Access PlatformSung Hye Kim, Milika Rinamalo, Meleresita Rainima-Qaniuci, et al.
The Journal of Urology|August 1, 1989
Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinomaJ H Schornagel, J Verweij, W W ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupM Debiec-Rychter, H Dumez, I Judson, et al.
British Journal of Cancer|December 25, 2013
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I studyP Hamberg, M J Boers-Sonderen, W T A van der Graaf, et al.
Anti-Cancer Drugs|August 13, 2002
The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumorsH Dumez, M Louwerens, A Pawinsky, et al.
Medical Mycology Case Reports|February 9, 2019
Two cases of <i>Emergomyces pasteurianus</i> infection in immunocompromised patients in the NetherlandsKarin B Gast, Alieke van der Hoeven, Mark G J de Boer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Journal of Extracellular Vesicles|November 7, 2024
Hypoxia and TNF-alpha modulate extracellular vesicle release from human induced pluripotent stem cell-derived cardiomyocytesMargarida Viola, Maarten P Bebelman, Renee G C Maas, et al.
Pageof 59